Press release
Gastroparesis Drugs Market Reach $6,486 Million At A CAGR of 4.7% From 2017 To 2023
For More Info, Get Sample : https://www.researchbeam.com/gastroparesis-drugs-market/request-sample
Rise in number of surgeries, which leads to postsurgical gastroparesis conditions is the major factor that contributes to the growth of the gastroparesis drugs market. Moreover, rise in diabetic population, increase in geriatric population, and introduction of novel drugs to control symptoms such as nausea and vomiting fuel the market growth. However, side effects related to gastroparesis drugs, time-consuming regulatory process for the approval of drugs, and complications in gastroparesis diagnosis hamper the growth of the market. Conversely, surge in demand for the development of user-friendly drugs, rise in healthcare infrastructure, and creative marketing initiatives by key vendors in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period.
The global gastroparesis drugs market is segmented on the basis of drug class, disease type, distribution channel, and region. Based on drug class, the market is divided into prokinetic agents, antiemetic agents, and botulinum toxin injections. By disease type, it is classified into diabetic gastroparesis, idiopathic gastroparesis, postsurgical gastroparesis, and others. Depending on distribution channel, it is categorized into hospitals, pharmacies, clinics, and e-commerce. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global gastroparesis drugs market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Enquire About Report : https://www.researchbeam.com/gastroparesis-drugs-market/enquire-about-report
KEY MARKET SEGMENTS
By Drug Class
• Prokinetic Agents
• Antiemetic Agents
• Botulinum Toxin Injections
By Disease Type
• Diabetic Gastroparesis
• Idiopathic Gastroparesis
• Post-surgical Gastroparesis
Others
• By End User
• Hospitals
• Pharmacies
• Clinics
• E-commerce
By Region
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA
Also Request For Discount : https://www.researchbeam.com/gastroparesis-drugs-market/purchase-enquiry
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Allergan, Plc.
• Abbott Laboratories (Abbott Arzneimittel GmbH)
• AstraZeneca Plc.
• Cadila Pharmaceuticals Ltd.
• ETX Pharma, Inc
• Evoke Pharma
• GlaxoSmithKline Plc.
• Neurogastrx, Inc.
• Valeant Pharmaceuticals International, Inc.
• Theravance Biopharma
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• Altos Therapeutics LLC
• Mylan N.V.
• Hexal AG
• CEVA Group PLC
• Takeda Pharmaceutical Company Ltd
Table Of Content
• CHAPTER 1 INTRODUCTION
• CHAPTER 2 EXECUTIVE SUMMARY
• CHAPTER 3 MARKET OVERVIEW
• CHAPTER 4 GASTROPARESIS DRUGS MARKET, BY DRUG CLASS
• CHAPTER 5 GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE
• CHAPTER 6 GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL
• CHAPTER 7 GASTROPARESIS DRUGS MARKET, BY REGION
• CHAPTER 8 COMPANY PROFILES
About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.
Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastroparesis Drugs Market Reach $6,486 Million At A CAGR of 4.7% From 2017 To 2023 here
News-ID: 943983 • Views: …
More Releases from Research Beam Market
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor…
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period…
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are…
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in…
More Releases for CHAPTER
New Chapter-by-Chapter Column to Spotlight Local Authors Across the Sandhills
SANFORD, N.C. - September 2025 - Sandhills.News is launching Chapter-by-Chapter, a new column dedicated to celebrating writers from Moore, Lee, and Harnett counties. The series will highlight books, authors, and storytelling that reflect the culture and creativity of the Sandhills region.
"This column is a way for neighbors to discover the writers in their own backyards," said Stephanie Sellers, editor of Sandhills.News. "It's about strengthening connections through literature and offering…
Austin Bankruptcy Lawyers Guide Clients Through Chapter 7 & Chapter 13 Filings
Austin Bankruptcy Lawyers helps individuals and families in Texas overcome debt through Chapter 7 and Chapter 13 filings. The firm's bankruptcy attorney in Texas offers personalized legal support, clear guidance, and long-term financial solutions.
Austin, TX - For many individuals and families in Austin, TX, who face overwhelming debt, bankruptcy provides a pathway to a fresh start. Austin Bankruptcy Lawyers provides comprehensive legal services for Chapter 7 and Chapter 13 filings.…
New Jersey Bankruptcy Attorney Daniel Straffi Clarifies Key Differences Between …
New Jersey bankruptcy attorney Daniel Straffi (https://www.straffilaw.com/what-is-the-difference-between-new-jersey-bankruptcy-chapter-7-and-chapter-13/), of Straffi & Straffi Attorneys at Law, sheds light on the critical distinctions between Chapter 7 and Chapter 13 bankruptcy for individuals and small businesses facing financial challenges. When unexpected circumstances such as job loss, illness, or divorce lead to overwhelming debt, understanding these two legal pathways can provide much-needed relief. Daniel Straffi explains how each option offers tailored solutions to help debtors…
Chapter 13 Lawyer Daniel Straffi Unveils Comprehensive Guide on Understanding Ch …
Chapter 13 lawyer [https://www.straffilaw.com/new-jersey-chapter-13-lawyer/] Daniel Straffi of Straffi & Straffi Attorneys at Law has recently published a detailed article enlightening individuals on the intricacies of Chapter 13 bankruptcy in New Jersey. This guide serves as an essential resource, offering clarity and direction for those grappling with significant debt and seeking financial rehabilitation.
The article by the Chapter 13 lawyer provides an in-depth look at the "wage earner's plan," which is tailored…
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Robert Wolf as the new Chapter President of AFEA’s Orange, CA Chapter.
With the addition of Robert Wolf as the new Chapter President, AFEA is expanding…
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Angelica Jones as the new Chapter President of AFEA’s Glendale, California Chapter.
With the addition of Angelica Jones as the new Chapter President, AFEA is expanding…
